We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is James Hamrick, MD, MPH, Chairman of the Caris Precision Oncology Alliance at Caris…
Continue Reading
What You Should Know:
– Lunit, a provider of AI for cancer diagnostics and precision oncology, and Labcorp, a global leader in innovative and comprehensive laboratory services, today announced a strategic collaborative initiative. The partnership…
Continue Reading
Prostate cancer (PCa) ranks among the most prevalent cancers in men worldwide. Biochemical recurrence (BCR) presents a major clinical challenge in PCa management, with significant prognostic heterogeneity observed among patients post-recurrence. This study aimed…
Continue Reading
What You Should Know:
– Artera, the developer of multimodal artificial intelligence (MMAI)-based prognostic and predictive cancer tests, announced today that the U.S. Food and Drug Administration (FDA) has granted De Novo authorization for ArteraAI…
Continue Reading
Seoul National University Hospital has recently unveiled a clinical decision support system for precision medicine treatment.WHY IT MATTERS
The SNUH POLARIS (Precision Oncology and Rare-Common Disease Supporter) is said to be the first of its…
What You Should Know:
– Mission Bio, a leader in single-cell multiomics solutions for precision medicine, today announced the launch of its Single-Cell Genotype and Targeted Gene Expression assay, expanding the capabilities of its Tapestri Platform…
Continue Reading
What You Should Know:
– Oxford Cancer Biomarkers Ltd (OCB), a leader in molecular precision cancer diagnostic tests, has today announced a new partnership with Mira Precision Health Inc.
– This collaboration aims to advance OCB’s…
Continue Reading
Spesana logo
What You Should Know:
– Aranscia, a global provider of award-winning clinical workflow and diagnostic technology solutions announced its strategic acquisition of Spesana and its best-in-class suite of patient navigation, clinical collaboration, and oncology…
Continue Reading
What You Should Know:
– ConcertAI announced a multi-year agreement with Bayer to leverage ConcertAI’s Translational360™ and AI SaaS solutions, which use artificial intelligence and machine learning (AI/ML)-derived insights to accelerate clinical development in precision…
Continue Reading
Healthcare data company ConcertAI announced a multi-year agreement with pharmaceutical and biotechnology giant Bayer to utilize ConcertAI’s Translational360 and AI SaaS offerings.The offerings use AI and machine learning-acquired insights to speed up clinical development…
Continue Reading
